MicroPort NeuroScientific Corporation (MICROPORT NEURO) aksje

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company provides NUMEN Silk, a electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for intracranial aneurysm, as well as liquid embolic agent for cerebral arteriovenous malformations. It also offers APOLLO intracranial stent system for intracranial atherosclerosis; Bridge rapamycin target eluting and Bridge MAX rapamycin target eluting vertebral artery stent system for vertebral artery stenosis; Diveer intracranial balloon dilatation catheter, intracranial drug-coated balloon catheter system, intracranial self-expanding rapamycin target eluting stent, and intracranial balloon-expandable rapamycin target eluting stent for intracranial stenosis; and Carotid stent system, Safecer embolic protection device, and PathFinder carotid balloon dilation catheter for carotid artery stenosis. In addition, the company provides NeuroHawk thrombectomy device, NeuroHawk pass17/21 and medibox thrombectomy device and accessories, Tigertriever revascularization device, WAVE-track intracranial aspiration catheter, X-track intracranial distal access catheter, and NeuroGuard neurovascular balloon guide catheter for acute ischemic stroke. Further, it offers U-track intracranial support catheter system, Fastrack microcatheter system, QUEEN-track and 17 Microcatheter, Veyronwire neurovascular guide wire, Sheathru delivery catheter, and filter extension tube for single use. The company was founded in 2004 and is headquartered in Shanghai, China.